These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31757595)

  • 21. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucoadhesive gellan gum hydrogel containing diphenyl diselenide-loaded nanocapsules presents improved anti-candida action in a mouse model of vulvovaginal candidiasis.
    Zimmermann ES; Ferreira LM; Denardi LB; Sari MHM; Cervi VF; Nogueira CW; Alves SH; Cruz L
    Eur J Pharm Sci; 2021 Dec; 167():106011. PubMed ID: 34537375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of Nerol, a natural plant active ingredient, against Candida albicans in vitro and in vivo.
    Wang Z; Yang K; Chen L; Yan R; Qu S; Li YX; Liu M; Zeng H; Tian J
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):5039-5052. PubMed ID: 32248438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and significance of drug resistance in vulvovaginal candidiasis.
    Spinillo A; Nicola S; Colonna L; Marangoni E; Cavanna C; Michelone G
    Gynecol Obstet Invest; 1994; 38(2):130-3. PubMed ID: 7959341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
    Araújo DE; de Oliveira AA; Cabral MDS; Costa AF; Silva BC; do Carmo Silva L; de Menezes LB; de Almeida Soares CM; Amaral AC; Pereira M
    Braz J Microbiol; 2020 Dec; 51(4):1465-1473. PubMed ID: 32638273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei.
    dos Santos Ramos MA; Calixto G; de Toledo LG; Bonifácio BV; dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Nanomedicine; 2015; 10():7455-66. PubMed ID: 26719688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis.
    Zhu YX; Shi Y; Fan SR; Liu XP; Yang J; Zhong SL
    BMC Infect Dis; 2019 May; 19(1):461. PubMed ID: 31117966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A therapeutic effect of Nigella sativa extract on female Wistar rats vulvovaginal candidiasis model.
    Rusda M; Ganis Siregar MF; Lelo A; Ilyas S; Akbari Ganie R; Effendi Y; Zaitun Hasibuan PA; Lia Iswara RR
    Med Glas (Zenica); 2020 Aug; 17(2):472-476. PubMed ID: 32153156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility and molecular typing of 115 Candida albicans isolates obtained from vulvovaginal candidiasis patients in 3 Shanghai maternity hospitals.
    Ying C; Zhang H; Tang Z; Chen H; Gao J; Yue C
    Med Mycol; 2016 May; 54(4):394-9. PubMed ID: 26468549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
    Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A
    Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Azole-Tolerant Endosomal Trafficking Mutant of Candida albicans Is Susceptible to Azole Treatment in a Mouse Model of Vaginal Candidiasis.
    Peters BM; Luna-Tapia A; Tournu H; Rybak JM; Rogers PD; Palmer GE
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.